251 related articles for article (PubMed ID: 31455019)
1. Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties.
Vernen F; Harvey PJ; Dias SA; Veiga AS; Huang YH; Craik DJ; Lawrence N; Troeira Henriques S
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31455019
[TBL] [Abstract][Full Text] [Related]
2. Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.
Vernen F; Craik DJ; Lawrence N; Troeira Henriques S
ACS Chem Biol; 2019 Dec; 14(12):2895-2908. PubMed ID: 31714739
[TBL] [Abstract][Full Text] [Related]
3. Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding.
Ramamoorthy A; Thennarasu S; Tan A; Gottipati K; Sreekumar S; Heyl DL; An FY; Shelburne CE
Biochemistry; 2006 May; 45(20):6529-40. PubMed ID: 16700563
[TBL] [Abstract][Full Text] [Related]
4. Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.
Edwards IA; Elliott AG; Kavanagh AM; Blaskovich MAT; Cooper MA
ACS Infect Dis; 2017 Dec; 3(12):917-926. PubMed ID: 28960954
[TBL] [Abstract][Full Text] [Related]
5. Modified horseshoe crab peptides target and kill bacteria inside host cells.
Amiss AS; von Pein JB; Webb JR; Condon ND; Harvey PJ; Phan MD; Schembri MA; Currie BJ; Sweet MJ; Craik DJ; Kapetanovic R; Henriques ST; Lawrence N
Cell Mol Life Sci; 2021 Dec; 79(1):38. PubMed ID: 34971427
[TBL] [Abstract][Full Text] [Related]
6. Structure-function relationships of tachyplesins and their analogues.
Iwanaga S; Muta T; Shigenaga T; Seki N; Kawano K; Katsu T; Kawabata S
Ciba Found Symp; 1994; 186():160-74; discussion 174-5. PubMed ID: 7768150
[TBL] [Abstract][Full Text] [Related]
7. Influences of disulfide connectivity on structure and antimicrobial activity of tachyplesin I.
Shi J; So LY; Chen F; Liang J; Chow HY; Wong KY; Wan S; Jiang T; Yu R
J Pept Sci; 2018 Jun; 24(6):e3087. PubMed ID: 29870123
[TBL] [Abstract][Full Text] [Related]
8. Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function.
Oren Z; Shai Y
Biochemistry; 2000 May; 39(20):6103-14. PubMed ID: 10821683
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of tachyplesin I injury to bacterial membranes and intracellular enzymes, determined by laser confocal scanning microscopy and flow cytometry.
Hong J; Guan W; Jin G; Zhao H; Jiang X; Dai J
Microbiol Res; 2015 Jan; 170():69-77. PubMed ID: 25267486
[TBL] [Abstract][Full Text] [Related]
10. Conformation and antimicrobial activity of linear derivatives of tachyplesin lacking disulfide bonds.
Rao AG
Arch Biochem Biophys; 1999 Jan; 361(1):127-34. PubMed ID: 9882437
[TBL] [Abstract][Full Text] [Related]
11. Action mechanism of tachyplesin I and effects of PEGylation.
Imura Y; Nishida M; Ogawa Y; Takakura Y; Matsuzaki K
Biochim Biophys Acta; 2007 May; 1768(5):1160-9. PubMed ID: 17320042
[TBL] [Abstract][Full Text] [Related]
12. Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.
Troeira Henriques S; Lawrence N; Chaousis S; Ravipati AS; Cheneval O; Benfield AH; Elliott AG; Kavanagh AM; Cooper MA; Chan LY; Huang YH; Craik DJ
ACS Chem Biol; 2017 Sep; 12(9):2324-2334. PubMed ID: 28741926
[TBL] [Abstract][Full Text] [Related]
13. Design of salt-insensitive glycine-rich antimicrobial peptides with cyclic tricystine structures.
Tam JP; Lu YA; Yang JL
Biochemistry; 2000 Jun; 39(24):7159-69. PubMed ID: 10852714
[TBL] [Abstract][Full Text] [Related]
14. Structure, activity and interactions of the cysteine deleted analog of tachyplesin-1 with lipopolysaccharide micelle: Mechanistic insights into outer-membrane permeabilization and endotoxin neutralization.
Saravanan R; Mohanram H; Joshi M; Domadia PN; Torres J; Ruedl C; Bhattacharjya S
Biochim Biophys Acta; 2012 Jul; 1818(7):1613-24. PubMed ID: 22464970
[TBL] [Abstract][Full Text] [Related]
15. Hairpin structure stability plays a role in the activity of two antimicrobial peptides.
Sivanesam K; Kier BL; Whedon SD; Chatterjee C; Andersen NH
FEBS Lett; 2016 Dec; 590(24):4480-4488. PubMed ID: 27859052
[TBL] [Abstract][Full Text] [Related]
16. Interaction between tachyplesin I, an antimicrobial peptide derived from horseshoe crab, and lipopolysaccharide.
Kushibiki T; Kamiya M; Aizawa T; Kumaki Y; Kikukawa T; Mizuguchi M; Demura M; Kawabata S; Kawano K
Biochim Biophys Acta; 2014 Mar; 1844(3):527-34. PubMed ID: 24389234
[TBL] [Abstract][Full Text] [Related]
17. Peptide-lipid interactions of the beta-hairpin antimicrobial peptide tachyplesin and its linear derivatives from solid-state NMR.
Doherty T; Waring AJ; Hong M
Biochim Biophys Acta; 2006 Sep; 1758(9):1285-91. PubMed ID: 16678119
[TBL] [Abstract][Full Text] [Related]
18. [Bacteria-selective synergism between the antimicrobial peptides magainin 2 and tachyplesin I: toward cocktail therapy].
Kobayashi S
Yakugaku Zasshi; 2002 Nov; 122(11):967-73. PubMed ID: 12440153
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro study on cytotoxicity of recombinant β-hairpin peptides.
Kuzmin DV; Emelianova AA; Kalashnikova MB; Panteleev PV; Balandin SV; Serebrovskaya EO; Belogurova-Ovchinnikova OY; Ovchinnikova TV
Chem Biol Drug Des; 2018 Jan; 91(1):294-303. PubMed ID: 28815904
[TBL] [Abstract][Full Text] [Related]
20. Dynamic structure of disulfide-removed linear analogs of tachyplesin-I in the lipid bilayer from solid-state NMR.
Doherty T; Waring AJ; Hong M
Biochemistry; 2008 Jan; 47(4):1105-16. PubMed ID: 18163648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
